REGN4461 - Mibavademab
R4461-MOB-2471
Phase 3 small_molecule active
Quick answer
REGN4461 - Mibavademab for Monogenic obesity is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Monogenic obesity
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active